Published in Int J Dermatol on October 01, 1976
Limited protection of rabbits against infection with Treponema pallidum by immune rabbit sera. Br J Vener Dis (1979) 1.16
Inability of spleen cells from chancre-immune rabbits to confer immunity to challenge with Treponema pallidum. Infect Immun (1977) 1.11
Modern neurosyphilis--a critical analysis. West J Med (1988) 1.10
Experimental infection of man with rabbit-virulent Treponema paraluis-cuniculi. Br J Vener Dis (1981) 1.07
Influence of testicular fluid infected with Treponema pallidum on intradermal lesions. Br J Vener Dis (1980) 0.96
Sequential changes in susceptibility to Treponema pallidum of rabbits previously infected with Treponema paraluis-cuniculi. Br J Vener Dis (1981) 0.94
Cloning structural genes for Treponema pallidum immunogens and characterisation of recombinant treponemal surface protein, P2 (P2 star). Genitourin Med (1987) 0.90
Rate of clearance of virulent Treponema pallidum (Nichols) from the blood stream of normal, Mycobacterium bovis BCG-treated, and immune syphilitic rabbits. Infect Immun (1980) 0.85
Langerhans cells in granulomatous syphilis. Arch Dermatol Res (1983) 0.82
Accelerated lesion development in experimental syphilis. Infect Immun (1981) 0.82
Susceptibility of rabbits to Treponema pallidum after infection with Mycobacterium bovis. Br J Vener Dis (1979) 0.81
Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis (2000) 7.80
Acute otitis media: management and surveillance in an era of pneumococcal resistance--a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr Infect Dis J (1999) 5.88
Urease. The primary cause of infection-induced urinary stones. Invest Urol (1976) 4.72
Haemophilus influenzae infections in adults: characterization of strains by serotypes, biotypes, and beta-lactamase production. J Infect Dis (1981) 3.45
Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity. Clin Infect Dis (1999) 3.15
Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Arch Intern Med (2000) 3.09
Geographic and temporal distribution and molecular characterization of two highly pathogenic clones of Streptococcus pyogenes expressing allelic variants of pyrogenic exotoxin A (Scarlet fever toxin). J Infect Dis (1993) 2.84
Disk diffusion susceptibility testing of Nocardia species. J Infect Dis (1977) 2.77
Severe diabetes associated with protease inhibitor therapy. Ann Intern Med (1997) 2.71
Effects of bovine serum albumin on the ability of Barbour-Stoenner-Kelly medium to detect Borrelia burgdorferi. J Clin Microbiol (1990) 2.60
Specificity of the FTA-ABS test for syphilis. JAMA (1969) 2.41
Vancomycin penetration into biofilm covering infected prostheses and effect on bacteria. J Infect Dis (1994) 2.37
Natural and vaccine-related immunity to Streptococcus pneumoniae. J Infect Dis (1986) 2.34
In vitro lymphocyte response to Treponema refringens im human syphilis. Infect Immun (1974) 2.27
Pneumonia and acute febrile tracheobronchitis due to haemophilus influenzae. Ann Intern Med (1983) 2.20
Lymphocyte transformation in syphilis: an in vitro correlate of immune suppression in vivo? Infect Immun (1975) 2.17
Clinical manifestations of halophilic non-cholera Vibrio infections. Lancet (1974) 2.14
Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus ("Streptococcus milleri group") are of different clinical importance and are not equally associated with abscess. Clin Infect Dis (2001) 2.13
Induction of lyme arthritis in LSH hamsters. Infect Immun (1988) 2.07
Interruption of capsule production in Streptococcus pneumonia serotype 3 by insertion of transposon Tn916. Infect Immun (1990) 2.06
Spontaneous, nontraumatic gangrene due to Clostridium septicum. Rev Infect Dis (1990) 2.06
Prevention of infected urinary stones by urease inhibition. Invest Urol (1973) 2.00
Association of invasive pneumococcal disease with season, atmospheric conditions, air pollution, and the isolation of respiratory viruses. Clin Infect Dis (1996) 1.98
Parenteral cephaloridine treatment of patients with early syphilis. Arch Intern Med (1968) 1.94
Antimicrobial activities of BMY-28142, cefbuperazone, and cefpiramide compared with those of other cephalosporins. Antimicrob Agents Chemother (1984) 1.91
Characterization of an unclassified microaerophilic bacterium associated with gastroenteritis. J Clin Microbiol (1988) 1.91
Treatment of gonorrhea with spectinomycin hydrochloride: comparison with standard penicillin schedules. Antimicrob Agents Chemother (1972) 1.86
Correlation of increased metabolic activity, resistance to infection, enhanced phagocytosis, and inhibition of bacterial growth by macrophages from Listeria- and BCG-infected mice. Infect Immun (1972) 1.85
Response of latent syphilis or neurosyphilis to ceftriaxone therapy in persons infected with human immunodeficiency virus. Am J Med (1992) 1.81
Characterization of the protective antibody response to Borrelia burgdorferi in experimentally infected LSH hamsters. Infect Immun (1991) 1.79
Inhibition of the antibacterial activity of gentamicin by urine. J Infect Dis (1976) 1.78
Pneumococcal virulence factors and host immune responses to them. Eur J Clin Microbiol Infect Dis (1995) 1.78
Monoclonal antibody analysis of specific antigenic similarities among pathogenic Treponema pallidum subspecies. Infect Immun (1984) 1.77
The diagnostic value of sputum culture in acute pneumonia. JAMA (1975) 1.75
An epidemic of pneumococcal disease in an overcrowded, inadequately ventilated jail. N Engl J Med (1994) 1.73
Development of bactericidal antibody during Branhamella catarrhalis infection. J Infect Dis (1985) 1.71
Role of urease in pyelonephritis resulting from urinary tract infection with Proteus. J Infect Dis (1975) 1.71
Bacterial spinal epidural abscess. Review of 43 cases and literature survey. Medicine (Baltimore) (1992) 1.71
Detection of nonspecific resistance to Listeria monocytogenes in rabbits infected with Treponema pallidum. Infect Immun (1974) 1.69
Hemophilus influenzae pneumonia in adults. Am J Med (1978) 1.69
Bacterial adherence to pharyngeal cells during viral infection. J Infect Dis (1980) 1.68
Passive immunization prevents induction of Lyme arthritis in LSH hamsters. Infect Immun (1990) 1.67
Emergence of variant forms of Staphylococcus aureus after exposure to gentamicin and infectivity of the variants in experimental animals. J Infect Dis (1977) 1.65
Histopathology of Lyme arthritis in LSH hamsters. Am J Pathol (1989) 1.63
Treatment of gonorrhoea with a single oral dose of minocycline. Br J Vener Dis (1971) 1.63
Opsonizing and bactericidal effects of normal human serum on nontypable Haemophilus influenzae. Infect Immun (1983) 1.62
Characterization of the borreliacidal antibody response to Borrelia burgdorferi in humans: a serodiagnostic test. J Infect Dis (1993) 1.62
Attachment of gonococci to sperm. Influence of physical and chemical factors. Br J Vener Dis (1976) 1.60
Elution of vancomycin, daptomycin, and amikacin from acrylic bone cement. Clin Orthop Relat Res (1991) 1.59
Polymicrobial bacteremia: clinical and microbiologic patterns. Rev Infect Dis (1989) 1.59
Case report of an unclassified microaerophilic bacterium associated with gastroenteritis. J Clin Microbiol (1988) 1.58
Inhibition of bacterial urease. Invest Urol (1973) 1.57
In vitro antimicrobial effect against Streptococcus pneumoniae of adding rifampin to penicillin, ceftriaxone, or 1-ofloxacin. Antimicrob Agents Chemother (1995) 1.56
Osteomyelitis associated with pressure sores. Arch Intern Med (1994) 1.56
Antimicrobial susceptibilities of Bordetella species isolated in a Multicenter Pertussis Surveillance Project. Antimicrob Agents Chemother (1988) 1.51
Performance of 45 laboratories participating in a proficiency testing program for Lyme disease serology. JAMA (1992) 1.51
Importance of protective borreliacidal antibodies in Lyme disease immunity and serodiagnosis. J Infect Dis (1994) 1.50
Mass cultivation of avirulent Treponema pallidum (Nichols). Microbios (1971) 1.49
Characterization of the protective borreliacidal antibody response in humans and hamsters after vaccination with a Borrelia burgdorferi outer surface protein A vaccine. J Infect Dis (1996) 1.48
Testing of Streptococcus pneumoniae for resistance to penicillin. J Clin Microbiol (1993) 1.46
Passive transfer of resistance to frambesial infection in hamsters. Infect Immun (1978) 1.45
Amebiasis presenting as pleuropulmonary disease. West J Med (1985) 1.45
Influence of wind on ultraviolet injury. Arch Dermatol (1974) 1.44
The FTA-ABS test in dark-field-positive primary syphilis. JAMA (1974) 1.43
Antibiotic-induced suprainfection. J Infect Dis (1969) 1.42
Borrelia burgdorferi infection surrounding La Crosse, Wis. J Clin Microbiol (1988) 1.41
Endemic syphilis: passive transfer of resistance with serum and cells in hamsters. J Infect Dis (1979) 1.40
Q fever. Arch Intern Med (1988) 1.39
Characterization of the antigenic determinants and host components in immune complexes from patients with secondary syphilis. J Immunol (1986) 1.38
Lyme disease assay which detects killed Borrelia burgdorferi. J Clin Microbiol (1991) 1.36
Phagocytosis and killing of Brucella by human polymorphonuclear leukocytes. J Infect Dis (1985) 1.35
Borreliacidal antibody production against outer surface protein C of Borrelia burgdorferi. J Infect Dis (1998) 1.34
Infections due to Staphylococcus aureus. Medicine (Baltimore) (1977) 1.34
Interaction between acetohydroxamic acid and 12 antibiotics against 14 gram-negative pathogenic bacteria. Antimicrob Agents Chemother (1974) 1.32
Antibody to capsular polysaccharides of Streptococcus pneumoniae after vaccination of human immunodeficiency virus-infected subjects with 23-valent pneumococcal vaccine. J Infect Dis (1992) 1.32
Development of destructive arthritis in vaccinated hamsters challenged with Borrelia burgdorferi. Infect Immun (1994) 1.30
Vertebral osteomyelitis. Still a diagnostic pitfall. Arch Intern Med (1976) 1.29
Borreliacidal activity of sera from hamsters infected with the Lyme disease spirochete. Infect Immun (1991) 1.28
Resistance of Vibrio vulnificus to serum bactericidal and opsonizing factors: relation to virulence in suckling mice and humans. J Infect Dis (1984) 1.27
Hypoglycemia as a manifestation of sepsis. Am J Med (1980) 1.26
Spinal epidural abscess. Med Clin North Am (1985) 1.26
Use of CB hamsters in the study of Treponema pertenue. Br J Vener Dis (1979) 1.26
Edouard Seguin and the social power of thermometry. N Engl J Med (1987) 1.26
Suppression of phagocytosis and chemotaxis by cell wall components of Staphylococcus aureus. J Immunol (1981) 1.25
Interlaboratory comparison of test results for detection of Lyme disease by 516 participants in the Wisconsin State Laboratory of Hygiene/College of American Pathologists Proficiency Testing Program. J Clin Microbiol (1997) 1.25
Diagnosing and treating cytomegalovirus pneumonia in patients with AIDS. Clin Infect Dis (1996) 1.24
Immunoglobulin A from bronchopulmonary secretions blocks bactericidal and opsonizing effects of antibody to nontypable Haemophilus influenzae. Infect Immun (1984) 1.24
Acquired resistance of hamsters to challenge with homologous and heterologous virulent treponemes. Infect Immun (1982) 1.23
Antibiotic susceptibilities of genetically characterized Streptococcus milleri group strains. Antimicrob Agents Chemother (2001) 1.23
Permanent carriers of nontyphosa salmonellae. Arch Intern Med (1973) 1.22
Aberrant secondary antibody responses to sheep erythrocytes in rabbits with experimental syphilis. Infect Immun (1979) 1.22
Wound zygomycosis (mucormycosis) in otherwise healthy adults. Am J Med (1988) 1.22
A brief history of the pneumococcus in biomedical research: a panoply of scientific discovery. Clin Infect Dis (1993) 1.21
Recovery of Haemophilus influenzae from twenty-three blood culture media. J Clin Microbiol (1979) 1.21
Effects of BCG infection on the susceptibility of mouse macrophages to endotoxin. Infect Immun (1979) 1.21